. Author manuscript; available in PMC: 2010 Oct 1.

Published in final edited form as: Appl Immunohistochem Mol Morphol. 2009 Oct;17(5):438–441. doi: 10.1097/PAI.0b013e3181993d86

Table 5.

Number of cores¹ with targeted area, per target diagnosis

Target lesion	Total cases	Number of cores with targeted area per case (%)
Target lesion	Total cases	≥1	1	2	3
Normal TDLUs	361	275(76.2)	95 (26.3)	97(26.9)	83 (23.0)
UDH	139	91 (65.5)	34 (24.5)	40 (28.8)	17 (12.2)
ADH	50	20 (40.0)	12 (24.0)	6 (12.0)	2 ( 4.0)
ALH	25	15 (60.0)	8 (32.0)	7 (28.0)	0 ( 0.0)

For lesions with greater than 3 cores, 3 cores were randomly selected.

TDLUs=terminal duct lobular units, UDH=usual ductal hyperplasia, ADH=atypical ductal hyperplasia, ALH=atypical lobular hyperplasia